Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure (Q68316139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

27 October 2022

author name string

B. Andersson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680132

27 October 2022

C. Blomström-Lundqvist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680132

27 October 2022

T. Hedner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680132

27 October 2022

F. Waagstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1680132

27 October 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0735109791907674?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

https://api.elsevier.com/content/article/PII:0735109791907674?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Journal of the American College of Cardiology

27 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

1059-1066

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

The Neurohumoral Axis in Congestive Heart Failure

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

27 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Inotropic therapy for heart failure: paradise postponed

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Haemodynamic effects of acute beta-adrenergic receptor blockade in congestive cardiomyopathy

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Beta-blockers in dilated cardiomyopathies: they work

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Measurement of coronary sinus blood flow by continuous thermodilution in man

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Can patients with coronary artery disease receiving beta blockers obtain a training effect?

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol

27 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy.

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Central effect of beta adrenergic blocking agents on arterial blood pressure

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Sympathetic outflow to muscles during treatment of hypertension with metoprolol

27 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension

27 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

The effect of beta blockers on total peripheral resistance

27 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Return of plasma norepinephrine to normal after resolution of congestive heart failure in congenital heart disease

27 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure

27 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

27 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy

27 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Haemodynamic and metabolic effects of timolol (Blocadren) on ischaemic myocardium

27 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Cardiovascular pharmacology of propranolol in man

27 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Improved myocardial lactate extraction after propranolol in coronary artery disease: effected by peripheral glutamate and free fatty acid metabolism

27 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Improvement of myocardial metabolism in coronary arterial disease by beta-blockade

27 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Effects of three bradycardiac drugs on regional myocardial blood flow and function in areas distal to a total or partial coronary occlusion in dogs

27 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise

27 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0735-1097(91)90767-4

27 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1680132%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference